Keyphrases
COVID-19
100%
Aerosolized
56%
Sanitation
50%
Ministry of Health
50%
Biobank
50%
Ebola
50%
Public Health England
50%
Cynomolgus Macaque
50%
Detergent
50%
Monkeypox Virus
50%
Infection Model
46%
Sierra Leone
41%
Nucleic Acid Extraction
39%
Ebola Virus
33%
High Dose
31%
Spleen
31%
Lung
31%
Public Health
31%
Smallpox Vaccine
30%
Virucidal Efficacy
29%
TCID50
28%
Quantitative PCR
28%
Rapid Test
28%
Commercially Available
28%
ACAM2000
25%
Accountable Care Organizations
25%
Specimen Transport Medium
25%
Speech Therapy
25%
Lee Silverman Voice Treatment
25%
IMVAMUNE
25%
Biobank Governance
25%
Inactivation Agent
25%
Heat Treatment Effect
25%
Guanidine
25%
Melioidosis
25%
Burkholderia Pseudomallei
25%
Language Therapy
25%
Cost-effectiveness
25%
Healthcare
25%
Clinical Serum Samples
25%
National Health Service
25%
Fixative
25%
Proviral DNA
25%
Parkinson's Disease
25%
Non-denaturing
25%
Third Generation
25%
Protective Effect
25%
Randomized Controlled Trial
25%
Toxicity Study
25%
New Zealand White Rabbit
25%
Multicenter Randomized Controlled Trial
25%
Dependant
25%
Aerosol Model
25%
Mouthwash
25%
Guanidinium
25%
Clinical Efficacy
25%
Spontaneous Expression
25%
Indecision
25%
Clinical Samples
23%
Triton X-100 (TX-100)
21%
Balb C Mice
18%
PCR Sensitivity
18%
Medical Countermeasures
18%
Smallpox
18%
Viral Load
17%
Monkeypox Infection
16%
Diagnostic Test
16%
Tonsil
16%
Immunostaining
16%
Colon
16%
Single Immunization
15%
Inactivation Methods
14%
Pathological Changes
14%
Monkeypox
13%
Clinical Observation
13%
LSVT LOUD
12%
Aerosolized Bacteria
12%
Plaque Assay
12%
Viable Virus
12%
Infectious Virus
12%
Etiological Agents
12%
Heat Treatment
12%
Heat Inactivation
12%
Ebola Outbreak
11%
Variola Virus
11%
Commissioners
10%
Prime-boost
10%
Virus
9%
Curation
8%
Equality of Access
8%
Low-middle Income Countries
8%
Public Health Strategies
8%
Valuable Resources
8%
Routine Diagnostics
8%
Sample Quality
8%
Commercial Companies
8%
Future Healthcare
8%
Clinical Specimens
8%
FDA Animal Rule
8%
Blood Concentration
8%
Medicine and Dentistry
Public Health
80%
Severe Acute Respiratory Syndrome Coronavirus 2
75%
Guanidine
50%
Nucleic Acid
39%
Ebolavirus
33%
Rapid Test
28%
Mouthwash
25%
National Health Service
25%
Fixative
25%
Buffer
25%
Accountable Care Organization
25%
Speech and Language Rehabilitation
25%
Parkinson's Disease
25%
Randomized Controlled Trial
25%
Cost-Effectiveness Analysis
25%
In Vitro
25%
Triton X 100
21%
COVID-19
17%
Diagnostic Testing
16%
Pathogen
13%
Health Care Cost
10%
Low and Middle Income Countries
8%
Speech Disorder
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
6%
Quality of Life
5%
Community Health
5%
Virus Infectivity
5%
Virus Inactivation
5%
Population Health
5%
Coronaviridae
5%
Health Inequality
5%
Ecological Study
5%
High Risk Population
5%